HomeFilePeripheral vascular disease

Peripheral vascular disease

Low vs High Dose Drug Coated Balloons in Femoropopliteal Territory

The use of drub coated balloons (DCB) in the treatment of femoropopliteal artery disease has grown. Studies...

TCT 2023 The LIFE-BTK Trial

This was a randomized study including 261 patients treated with infrapatellar percutaneous transluminal angioplasty.173 of these patients...

SOLACI-SBHCI 2023 | Tips and Tricks with Renal Denervation – Dr. María Sanalí Paiva

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. María...

SOLACI-SBHCI 2023 | Insights from the LATAM Peripheral Registry – Dr. Maximiliano Rossi

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Maximiliano...

SOLACI-SBHCI 2023 | Acute pulmonary embolysmworkflow: Patient Screening & Endovascular treatment indications – Dr. João Luiz Frighetto

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. João...

SOLACI-SBHCI 2023 | AORTIC ANEURYSM FROM THE GUIDELINES TO THE REAL WORLD – Dr. Felix Damas de los Santos

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Felix...

Device Effectiveness for Femoropopliteal Artery Disease Treatment: Analysis of K-VIS ELLA Registry

Endovascular treatment of lesions in femoropopliteal territory (FPA) has become the main therapeutic option, seeing as it...

Simplified Rapid Intravenous Hydration for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease

Patients with chronic kidney disease (CKD) undergoing coronary angiography are at increased risk of developing contrast-associated acute...